Accretion Pharmaceuticals Limited vs Apollo Hospitals Enterprise Limited
A side-by-side comparison of Accretion Pharmaceuticals Limited (ACCPL) and Apollo Hospitals Enterprise Limited (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Accretion Pharmaceuticals Limited leads ACCPL vs APOLLOHOSP on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability31
- Growth20
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ACCPL takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
ACCPL takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 41.6%"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend"]
- + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
- − ["Stock is trading at 11.97 times its book value"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.